Novo Nordisk sees soaring demand for Ozempic and Wegovy as label expansions and manufacturing boosts fuel obesity market gains.

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the title at the company.

Share or comment on this article: Lizzo puts Ozempic results on full display in tiny swimsuit after coming clean about weight loss aid ...

Actor Ram Kapoor made headlines a few months ago for his dramatic weight loss and physical transformation.

Novo Nordisk, the Danish pharma company behind Ozempic, made a very dumb decision a few years ago that will massively eat into its profits.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Financial services firm Redburn Atlantic says McDonald's is in trouble, due to weight loss drugs like Ozempic.

Ram Kapoor defended the use of Ozempic for weight loss, emphasising that it requires a doctor's prescription. He criticised societal negativity around its use.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.